NIH Funding and Other Translational Research Opportunities

Tuesday April 27, 2021

12:00 pm - 1:30 pm Eastern Time (ET)

View session on the EB Virtual Platform (EB registration required)

BEH DCP CVP DDD DMDD MP NEU TOX TCP

Chair :

Rebecca Roof
National Institute of Neurological Disorders and Stroke (NINDS), NIH

Sailaja Koduri
National Institute of General Medical Sciences (NIGMS), NIH



Panel members from scientifically diverse offices within the National Institutes of Health (NIH) will provide information on funding opportunities, resources, and institute interests. The panel will discuss how to get NIH funding for EB-related research and other opportunities as well as tips for success. Special attention will be given to training opportunites. Discussion will focus on both long-standing NIH interests as well as new initiatives in translation. During the session, a significant amount of time will be allotted for questions from the audience.

Speakers

Bobbie Mount - National Center for Advancing Translational Sciences (NCATS), NIH

Drug Development Collaboratory

Collaboratory means a center without walls. This presentations covers an opportunity for IND-enabling support and clinical trial support for therapeutic development of small molecules, biologics, or gene therapies.

Daniel Gossett - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH

Funding and Other Opportunities at NIDDK

The mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic disease; digestive diseases, nutritional disorders and obesity; and kidney, urologic, and hematologic diseases, to improve people's health and quality of life. In support of its mission, NIDDK participates in a series of funding opportunity announcements to encourage translation of basic discoveries to novel therapeutics. These funding opportunities span the typical pipeline for discovery and development of novel therapeutics, from target identification to clinical development, and include R01 and small business grant mechanisms. The NIDDK also supports a variety of other resources and programs to bolster research activities along this pipeline.

Lesly-Anne Samedy-Bates - National Institute of Child Health and Human Development (NICHD)

Training Program at NICHD

NICHD supports the full spectrum of basic, translational and clinical research in areas relevant to normal and abnormal human development. In this presentation, you will learn about NICHD’s initiatives and priorities in the areas of pharmacology and tranlational research on the safety and efficacy of the therapeutics and new drug development for maternal and pediatric populations. You will also learn about research funding opportunities in the areas of molecular targets, biomarkers, therapeutic devices and pediatric formulations as well as the NICHD pharmacology and therapeutics training program.

Hye-Sook Kim - National Center for Complementary and Integrative Health (NCCIH)

NIH Natural Product Research: Investigating Safety and Mechanisms

In this presentation, you will learn how NCCIH supports research on the development and optimization of safe and promising natural products, including dietary supplements, botanicals, prebiotics, and probiotics etc that may be used or developed to manage symptoms, promote health, resilience and prevent diseases. NCCIH-funded research also delves into the biological mechanisms of actions of natural products and their interactions with drugs. NCCIH funding opportunities range from candidate natural product discovery, lead optimization, preclinical study to clinical development.

Sailaja Koduri - National Institute of General Medical Sciences (NIGMS), NIH

Research and Training Funding Opportunities at NIGMS

The National Institute of General Medical Sciences (NIGMS) supports basic research that increases our understand of biological processes and lays the foundation for advances in disease diagnosis, treatment and prevention. In this presentation, you will learn research supported by NIGMS that takes a multifaceted approach to problems in pharmacology, physiology, biochemistry, and biological chemistry that are very basic in nature. The goals of supported research include an improved understanding of drug action and of anesthesia; mechanisms underlying responses to drugs; new methods and targets for drug discovery; advances in natural products synthesis; an enhanced understanding of biological catalysis; and research on anesthesia, burn injury, sepsis, and trauma. In addition, Information on NIGMS training funding opportunities will be shared.

Rebecca Roof - National Institute of Neurological Disorders and Stroke (NINDS), NIH

Funding and Resources at the NINDS Division of Translational Research

The mission of the National Institute of Neurological Disorders and Stroke (NINDS) Division of Translational Research (DTR) is to accelerate basic research findings towards patient use for neurological disorders and stroke by providing funding, expertise, and resources to the research community. DTR provides finding and resources (approximately $100 million annually) through grants, cooperative agreements, and contract to academic and industry researchers to advance early-stage neurological technologies, devices and therapeutic programs to industry adoption (i.e., investor funding and corporate partnerships). DTR offers a variety of programs that support the design, implementation and management of research activities critical to translational challenges in the treatment of neurological disease.

Sailaja Koduri - National Institute of General Medical Sciences (NIGMS), NIH

NIH Funding Opportunities-Overview

This presentation will provide an overview of NIH research and training funding opportunities. NIH programs help prepare individuals for careers in biomedical, behavioral, social, and clinical research. Funding opportunities for students, postdoctoral fellows and early stage investigators will be highlighted. The research and training funding supported by NIH institutes may vary and institute-specific information will be presented by speakers participating in this session.

Last Updated: February 8, 2021
Key Dates
 
April 27 – 30, 2021

ASPET Annual Meeting at EB 2021

Thank you to our Annual Meeting partners:

jpet_banner
molpharm_banner
dmd_banner
pharmrev_banner